IDEXX LABORATORIES INC /DE·4

May 14, 5:00 PM ET

SAMAD SAM 4

4 · IDEXX LABORATORIES INC /DE · Filed May 14, 2026

Research Summary

AI-generated summary of this filing

Updated

IDEXX (IDXX) Director SAMAD SAM Receives Stock Awards

What Happened

  • SAMAD SAM, a director of IDEXX Laboratories, received two types of equity awards on 2026-05-12: 525 option shares (derivative) and 234 deferred stock units (derivative). Both awards are reported at $0.00 (grant value reported as acquisition price) and do not represent an immediate purchase or sale of common stock.
  • These awards total 759 contingent awards. The options give a right to buy common stock (see footnote F1); the deferred stock units represent contingent rights to receive one share each (see footnote F2).

Key Details

  • Transaction date: 2026-05-12; Form 4 filed: 2026-05-14 (filed within the usual two-business-day window).
  • Items granted: 525 options (F1) and 234 deferred stock units (F2); both reported at $0.00 acquisition price.
  • Vesting: Both awards vest in one installment on the one‑year anniversary of the grant or on the date of the 2027 annual meeting of shareholders, whichever is earlier.
  • Deferred stock units: by default payable as common stock as soon as practicable following a director’s resignation (per F2).
  • Shares owned after the transaction: not disclosed in this filing.

Context

  • These are director compensation grants (award code A), not open‑market purchases or sales; they create potential future ownership if/when vesting and any option exercises occur.
  • For retail investors, such grants are routine for board members and do not by themselves signal near‑term buying or selling.

Insider Transaction Report

Form 4
Period: 2026-05-12
SAMAD SAM
Director
Transactions
  • Award

    Non-Qualified Stock Option (right-to-buy)

    [F1]
    2026-05-12+525525 total
    Exercise: $533.92Exp: 2036-05-11Common Stock (525 underlying)
  • Award

    Deferred Stock Unit

    [F2]
    2026-05-12+2341,354 total
    Common Stock (234 underlying)
Footnotes (2)
  • [F1]Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.
  • [F2]Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Sam Samad|2026-05-14

Documents

1 file
  • 4
    wk-form4_1778792452.xmlPrimary

    FORM 4